title: N-substituted piperidinyl alkyl imidazoles: discovery of methimepip as a potent and selective histamine H3 receptor agonist.
abstract: In this study, we continue our efforts toward the development of potent and highly selective histamine H(3) receptor agonists. We introduced various alkyl or aryl alkyl groups on the piperidine nitrogen of the known H(3)/H(4) agonist immepip and its analogues (1-3a). We observed that N-methyl-substituted immepip (methimepip) exhibits high affinity and agonist activity at the human histamine H(3) receptor (pK(i) = 9.0 and pEC(50) = 9.5) with a 2000-fold selectivity at the human H(3) receptor over the human H(4) receptor and more than a 10000-fold selectivity over the human histamine H(1) and H(2) receptors. Methimepip was also very effective as an H(3) receptor agonist at the guinea pig ileum (pD(2) = 8.26). Moreover, in vivo microdialysis (in rat brain) showed that methimepip reduces the basal level of brain histamine to about 25% after a 5 mg/kg intraperitoneal administration.
authors.affiliation: Faculty of Chemistry, Department of Pharmacochemistry, Division of Medicinal Chemistry, Leiden/Amsterdam Center of Drug Research, Vrije Universiteit Amsterdam, De Boelelaan 1083, 1081 HV Amsterdam, The Netherlands.
authors.forename: Ruengwit
authors.initials: R
authors.lastname: Kitbunnadaj
authors.forename: Takeshi
authors.initials: T
authors.lastname: Hashimoto
authors.forename: Enzo
authors.initials: E
authors.lastname: Poli
authors.forename: Obbe P
authors.initials: OP
authors.lastname: Zuiderveld
authors.forename: Alessandro
authors.initials: A
authors.lastname: Menozzi
authors.forename: Ryoko
authors.initials: R
authors.lastname: Hidaka
authors.forename: Iwan J P
authors.initials: IJ
authors.lastname: de Esch
authors.forename: Remko A
authors.initials: RA
authors.lastname: Bakker
authors.forename: Wiro M P B
authors.initials: WM
authors.lastname: Menge
authors.forename: Atsushi
authors.initials: A
authors.lastname: Yamatodani
authors.forename: Gabriella
authors.initials: G
authors.lastname: Coruzzi
authors.forename: Henk
authors.initials: H
authors.lastname: Timmerman
authors.forename: Rob
authors.initials: R
authors.lastname: Leurs
mesh_terms: D000818:Animals; D001667:Binding, Competitive; D002460:Cell Line; D002522:Chlorocebus aethiops; D006224:Cricetinae; D003412:Cricetulus; D004558:Electric Stimulation; D006168:Guinea Pigs; D006632:Histamine / Q000378:metabolism; D017442:Histamine Agonists / Q000138:chemical synthesis* / Q000737:chemistry / Q000494:pharmacology; D006801:Humans; D007031:Hypothalamus / Q000378:metabolism; D007082:Ileum / Q000187:drug effects / Q000502:physiology; D007093:Imidazoles / Q000138:chemical synthesis* / Q000737:chemistry / Q000494:pharmacology; D066298:In Vitro Techniques; D008297:Male; D017551:Microdialysis; D009119:Muscle Contraction / Q000187:drug effects; D009130:Muscle, Smooth / Q000187:drug effects / Q000502:physiology; D010880:Piperidines / Q000138:chemical synthesis* / Q000737:chemistry / Q000494:pharmacology; D011869:Radioligand Assay; D051381:Rats; D017208:Rats, Wistar; D018100:Receptors, Histamine H3 / Q000187:drug effects*
chemical_list: C500075:4-(imidazol-4-ylmethyl)-1-methylpiperidine; D017442:Histamine Agonists; D007093:Imidazoles; D010880:Piperidines; D018100:Receptors, Histamine H3; C085755:4-(1H-imidazol-4-ylmethyl)piperidine; D006632:Histamine